NKTR- Nektar Therapeutics

Insider activity in NKTR over the last quarter tilts toward selling: insiders offloaded a net 604 shares worth roughly $43K.

Classified under Biotechnology (Health Care sector), NKTR's insider flows are most useful compared with peers in the same group.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Robin Howard W	54.6K	$3.93M	-
Other	Wilson Mark Andrew	21.6K	$1.17M	-
Dir	Chess Robert	19.0K	-	-
Dir	Whitfield Roy A	16.4K	-	-
Other	Zalevsky Jonathan	9.6K	$688.8K	-

Buys and sells only

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 25, 2025	Zalevsky Jonathan63	Chief R&D Officer	Sell	1,157	$54.28	$62,801.96	-5.7%	+21.9%	-
Nov 25, 2025	Wilson Mark Andrew58	Chief Legal Officer	Sell	630	$54.28	$34,196.40	-2.8%	+21.9%	-
Nov 25, 2025	Robin Howard W58	President &CEO	Sell	2,207	$54.28	$119,795.96	-3.9%	+21.9%	-
Sep 9, 2025	Robin Howard W58	President &CEO	Sell	6,666	$46.69	$311,214.24	-11.9%	+17.9%	+51.0%
Sep 5, 2025	Robin Howard W58	President &CEO	Sell	11,832	$36.42	$430,958.59	-17.4%	+43.6%	+84.6%
Sep 4, 2025	Zalevsky Jonathan63	Chief R&D Officer	Sell	1,721	$33.52	$57,692.51	-9.0%	+58.8%	+106.2%
Sep 2, 2025	Zalevsky Jonathan63	Chief R&D Officer	Sell	485	$30.10	$14,598.50	-2.5%	+110.1%	+150.1%
Sep 2, 2025	Robin Howard W58	President &CEO	Sell	1,500	$30.16	$45,240.00	-2.2%	+110.1%	+150.1%
Aug 19, 2025	Wilson Mark Andrew58	Chief Legal Officer	Sell	676	$26.59	$17,974.84	-3.2%	+123.0%	+184.7%
Aug 19, 2025	Robin Howard W58	President &CEO	Sell	1,573	$26.59	$41,826.07	-2.2%	+123.0%	+184.7%